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A Sinister Dexter Conundrum*Markus Meyer, MDI n response to external demands, the myocar-dium undergoes adaptive changes. This processhas been termed cardiac plasticity, and changes
at the macroscopic and cellular levels under various
environmental conditions have been documented
(1). The most basic response to increased volume or
pressure loading is an increase in cardiac muscle
mass (2). Within this context, concentric left ventric-
ular hypertrophy is the most prevalent and best un-
derstood cardiac adaptation, and many of the
pathways triggered by pathological hemodynamic
and neurohumoral stimuli have been identiﬁed (3).
The mechanisms that lead to right ventricular hyper-
trophy in response to pulmonary arterial hyperten-
sion (PAH) have undergone less research, but similar
basic concepts probably apply. However, in the right
ventricle, this adaptive change is frequently associ-
ated with eccentric remodeling and contractile
dysfunction, especially in patients with congenital
heart disease, in whom the development of PAH is
often preceded by a chronic volume load.SEE PAGE 28Ventricular interdependence, which is mandated
by a serial circulatory system, pericardial restraints,
and the shared myocardium of the septum, affects left
ventricular geometry and function. In severe pulmo-
nary hypertension, this is manifest as a ﬂattened
ventricular septum, which gives the left ventricle its
characteristic D shape. But there are other more subtle
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often appears “small and underﬁlled.” This observa-
tion has been recently conﬁrmed and quantiﬁed in
patients with pulmonary hypertension from occlusive
pulmonary vascular disease. The most prominent
ﬁndings from these studies are reductions in left
ventricular end-diastolic volume, stroke volume, and
ejection fraction (4,5). Some studies also suggest that
the mass of the left ventricular free wall may be
reduced (6). As a result, it has been proposed that the
left ventricle in patients with severe PAH undergoes
an adaptive atrophic change that is opposite to the
hypertrophy of the right ventricle. This coexistence of
a diametrically opposed growth response provides a
revealing insight into the mechanisms and pathways
that govern myocardial adaptation. The work load
imposed on the ventricle must be the primary deter-
minant of the growth response, as systemic variables
(i.e., neurohumoral factors) would unlikely trigger a
disparate response. This, however, raises the question
of why the left ventricle appears to atrophy in severe
PAH. One possible explanation is a reduction in
left ventricular ﬁlling or at the minimum a reduction
in the normal variation in left ventricular inﬂow.
Normally, the pulmonary vascular bed can readily
accommodate a several-fold increase in blood ﬂow.
This allows a normal cardiac output reserve, and the
associated ﬂuctuations in volume load provide a
growth stimulus. This variation in ﬂow is reduced in
patients with PAH, which results in a sheltered and
unchallenged left ventricle. Further progression of the
underlying pulmonary vasculopathy and right ven-
tricular failure will ultimately reduce left ventricular
ﬁlling and cardiac output at rest. Other growth stimuli
and contributors to cardiac work load, such as preload
and heart rate, undoubtedly also inﬂuence this
process in less predictable ways. However, chronic
underutilization provides the most plausible expla-
nation for left ventricular atrophy in PAH, as similar
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FIGURE 1 Principal Clinical and Cellular Changes in Left Ventricular Atrophy
EDV ¼ end-diastolic volume; HR ¼ heart rate; SV ¼ stroke volume.
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39changes are reported in mitral stenosis and in other
settings (7). Extreme physical inactivity induced by
bed rest or zero-gravity conditions in healthy subjects
has been demonstrated to reduce left ventricular
chamber volume and myocardial mass within days to
weeks (8,9). These studies demonstrated that the
reduction in left ventricular cavity size typically pre-
cedes the loss in left ventricular mass (Fig. 1). The
reported reductions in end-diastolic volume are
approximately 10% to 20%, and the reductions in mass
are 5% to 15%, depending on the duration of the
exposure. A potential maximum in mass reduction of
25% to 35% has been reported in patients with tetra-
plegia, as this occurs in the context of a complete
cessation of all physical activity (10). Left ventricular
atrophy also appears to play a role in aging and a
sedentary life-style (11).
Besides the clinically measurable changes in left
ventricular structure and function, not much is
known about the mechanisms and pathways that lead
to myocardial atrophy. This is due in part to the
inherent difﬁculty in obtaining myocardial tissue
from patients and the fact that the majority of animal
models do not reproduce the chronicity of the human
disease process. Sufﬁcient quantities of human
myocardium typically only become available when
patients with end-stage conditions undergo cardiac
transplantation, which also provides an opportunity
to procure donor tissue. Despite some experimental
limitations, these studies have been very valuable to
our understanding of various myocardial disease
processes. In a laudable undertaking, Manders et al.(12) provide us with a ﬁrst insight into the cellular and
molecular alterations associated with left ventricular
atrophy in patients. At the morphometric cellular
level, they found that left ventricular cardiac myo-
cytes from patients with end-stage PAH are thinner
compared with myocytes from donor hearts. The in-
vestigators explain this ﬁnding by a lower cellular
content of the contractile protein myosin, which
dominates the protein composition of the cardiac
myocyte. In the next set of experiments, the in-
vestigators conﬁrmed that the atrophied, smaller
cells have indeed a reduced force-generating capac-
ity. They also determined that the relative force
generation at submaximal calcium concentrations is
greater, which is manifest as a leftward shift in the
calcium-force curve. In other words, the interaction
of myosin and actin appears to be more sensitive to
calcium, which is the main mediator of force gener-
ation. Under the assumption that there is no change
in calcium cycling, this may represent a partially
compensatory mechanism but also could explain the
impairment in left ventricular diastolic function that
has been reported with this condition (13). The
investigators also provide us with a potential expla-
nation as to why cardiac troponin I and cardiac
myosin–binding protein C, which both regulate the
contractile proteins, are less phosphorylated. These
results have clinical relevance because patients with
end-stage PAH who receive donor lungs can develop
left ventricular failure, which is believed to be due to
the re-exposure of the left ventricle to higher work-
loads (14).
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40However, similar to related transplantation-based
myocardial tissue studies, there are some inevitable
limitations in the experimental approach, mainly a
small sample size and the pooling of World Health
Organization group 1 patients with variable initiating
etiologies.
Nonetheless, this study demonstrates left ventric-
ular atrophy at the cellular and molecular levels in
patients. It appears likely that other mechanisms and
pathways will be found, and it is certain that many
new questions will arise as we better understand thisprincipally reversible physiological adaptation (10,11).
An interesting question that came to mind concerns
the adaptive response and functional afﬁliation of
septal myocytes in this setting of a conﬂicting growth
stimulus. Left, right, or both?
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